Assembly Biosciences, Inc. Forecast, price target & analysts
$10.82
1.12%
yesterday
Nasdaq,
Apr 28, 09:45 pm CET
Assembly Biosciences, Inc. Target price 2025 - Analyst rating & recommendation
Powered by
Assembly Biosciences, Inc. Classifications & Recommendation:
Buy
67%
Hold
33%
Assembly Biosciences, Inc. Price Target
| Target Price | $33.50 |
| Price | $10.82 |
| Potential |
209.61%
register free of charge
|
| Number of Estimates | 2 |
|
2 Analysts have issued a price target Assembly Biosciences, Inc. 2026 .
The average Assembly Biosciences, Inc. target price is $33.50.
This is
209.61%
register free of charge
$36.00
232.72%
register free of charge
$31.00
186.51%
register free of charge
|
|
| A rating was issued by 3 analysts: 2 Analysts recommend Assembly Biosciences, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Assembly Biosciences, Inc. stock has an average upside potential 2026 of
209.61%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 28.52 | 31.66 |
| 298.32% | 11.00% |
3 Analysts have issued a sales forecast Assembly Biosciences, Inc. 2025 . The average Assembly Biosciences, Inc. sales estimate is
$31.7m
Unlock
11.00%
higher
Unlock
$33.7m
18.17%
Unlock
$28.3m
0.89%
Unlock
This results in the following potential growth metrics:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| EV/Sales | negative |
Current Assembly Biosciences, Inc. Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Guggenheim |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 24 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 27 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 24 2024 |
| Jefferies |
Locked
➜
Locked
|
Locked | Sep 20 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Guggenheim:
Locked
➜
Locked
|
Mar 25 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 24 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 27 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 24 2024 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Sep 20 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
